Relationship of impairment induced by intracellular S-adenosylhomocysteine accumulation with DNA methylation in human umbilical vein endothelial cells treated with 3-deazaadenosine

International Journal of Experimental Pathology

Volumn 90, Issue 6, 2009, Pages 638-648

  Yu, Xiaoping ^a,b,c   Ling, Wenhua ^b   Mi, Mantian ^c  

^a CHENGDU MEDICAL COLLEGE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

3 deazaadenosine; DNA methyltransferase 1; Extracellular superoxide dismutase; Methylation; Monocyte chemoattractant protein 1; Oestrogen receptor alpha; S adenosylhomocysteine

Indexed keywords

3 DEAZAADENOSINE; BIOLOGICAL MARKER; DNA METHYLTRANSFERASE 1; ESTROGEN RECEPTOR ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; S ADENOSYLHOMOCYSTEINE; SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

APOPTOSIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CHEMOKINE CCL2; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENDOTHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; INTRACELLULAR MEMBRANES; L-LACTATE DEHYDROGENASE; MICROSCOPY, ELECTRON; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; S-ADENOSYLHOMOCYSTEINE; SUPEROXIDE DISMUTASE; TUBERCIDIN; UMBILICAL VEINS;

EID: 71449125760     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00687.x     Document Type: Article

References (60)

1. Ambrosi P., Rolland P.H., Bodard H. et al. (1999) Effects of folate supplementation in hyperhomocysteinemic pigs. J. Am. Coll. Cardiol. 34, 274 279.
2. Auer J., Rammer M., Berent R., Weber T., Lassnig E., Eber B. (2002) Lack of association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis. Acta Cardiol. 57, 409 414.
3. Boers G.H. (2000) Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Semin. Thromb. Hemost. 26, 291 295.
4. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049 1057.
5. Boyle J.J. (2005) Macrophage activation in atherosclerosis pathogenesis and pharmacology of plaque rupture. Curr. Vasc. Pharmacol. 3, 63 68.
6. Brattstrom L. Wilcken D.E. (2000) Homocysteine and cardiovascular disease: cause or effect? Am. J. Clin. Nutr. 72, 315 323.
7. Castro R., Rivera I., Struys E.A. et al. (2003) Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 49, 1292 1296.
8. Castro R., Rivera I., Martins C. et al. (2005) Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J. Mol. Med. 83, 831 836.
9. Castro R., Rivera I., Blom H.J., Jakobs C., de Almeida I.T. (2006) Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J. Inherit. Metab. Dis. 29, 3 20.
10. Caudill M.A., Wang J.C., Melnyk S. et al. (2006) Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 131, 2811 2818.
11. Chen Z., Karaplis A.C., Ackerman S.L. et al. (2001) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10, 433 443.
12. Christopher S.A., Melnyk S., James S.J., Kruger W.D. (2002) S-adenosylhomocysteine, but not homocysteine, is toxic to yeast lacking cystathionine beta-synthase. Mol. Genet. Metab. 75, 335 343.
13. Clarke R. (1998) Homocysteine and cardiovascular disease. Overview. J. Cardiovasc. Risk 5, 213 215.
14. Damiel K.W., Stanley J.D., Baucer E.S. (2000) Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells. Surgery 128, 59 63.
15. Dayal S., Bottiglieri T., Arning E. et al. (2001) Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase- deficient mice. Circ. Res. 88, 1203 1209.
16. Dong C.M., Yoon W.H., Goldschmidt-Clermont P.J. (2002) DNA methylation and atherosclerosis. J. Nutr. 132, 2406S 2409S.
17. Fruchart J.C., Nierman M.C., Stroes E.S., Kastelein J.J., Duriez P. (2004) New risk factors for atherosclerosis and patient risk assessment. Circulation 109, 15 19.
18. Fu W., Dudman N.P., Perry M.A., Young K., Wang X.L. (2000) Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine. Biochem. Biophys. Res. Commun. 271, 47 53.
19. Hadi H.A., Carr C.S., Al Suwaidi J. (2005) Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc. Health. Risk. Manag. 1, 183 198.
20. Harker L.A., Slichter S.J., Scott C.R., Ross R. (1974) Homocystinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med. 291, 537 543.
21. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93, 9821 9826.
22. Hiltunen M.O. Ylä-Herttuala S. (2003) DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 23, 1750 1753.
23. Hiltunen M.O., Turunen M.P., Hakkinen T.P. et al. (2002) DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc. Med. 7, 5 11.
24. Holliday R. (2006) The inheritance of epigenetic defects. Science 238, 163 170.
25. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., Williams R.R. (1997) Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 17, 2783 2792.
26. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. (2006) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745 2756.
27. James S.J., Melnyk S., Pogribna M., Pogribny I.P., Caudill M.A. (2002) Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 132, 2361S 2366S.
28. Jeong S.Y., Ahn S.G., Lee J.H. et al. (1999) 3-deazaadenosine, a S-adenosylhomocysteine hydrolase inhibitor, has dual effects on NF-kappaB regulation. Inhibition of NF-kappaB transcriptional activity and promotion of IkappaBalpha degradation. J. Biol. Chem. 274, 18981 18988.
29. Kerins D.M., Koury M.J., Capdevila A., Rana S., Wagner C. (2000) Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am. J. Clin. Nutr. 74, 723 729.
30. Kinlay S. Egido J. (2006) Inflammatory biomarkers in stable atherosclerosis. Am. J. Cardiol. 98, 2 8.
31. Kortelainen M.L. Huttunen P. (2004) Expression of estrogen receptors in the coronary arteries of young and premenopausal women in relation to central obesity. Int. J. Obes. Relat. Metab. Disord. 28, 623 627.
32. Laukkanen M.O., Mannermaa S., Hiltunen M.O. et al. (1999) Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler. Thromb. Vasc. Biol. 19, 2171 2178.
33. Lee M.E. Wang H. (2006) Homocysteine and hypomethylation. A novel link to vascular disease. Trends Cardiovasc. Med. 9, 49 54.
34. Lentz S.R., Piegors D.J., Malinow M.R., Heistad D.D. (2001) Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys. Circulation 103, 1006 1011.
35. Lund G., Andersson L., Lauria M. et al. (2004) DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J. Biol. Chem. 279, 29147 29154.
36. McCully K.S. (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56, 111 128.
37. Melnyk S., Pogribna M., Pogribny I.P., Yi P., James S.J. (2000) Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5′-phosphate concentrations. Clin. Chem. 46, 265 272.
38. van der Molen E.F., Hiipakka M.J., van Lith-Zanders H. et al. (1997) Homocysteine metabolism in endothelial cells of a patient homozygous for cystathionine beta-synthase (CS) deficiency. Thromb. Haemost. 78, 827 833.
39. Morita H., Kurihara H., Yoshida S. et al. (2001) Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation 103, 133 139.
40. Naushad S., Jamal N.J., Angalena R., Prasad C.K., Devi A.R. (2007) Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians. Blood Coagul. Fibrinolysis 18, 113 117.
41. O'Grady H., Kelly C., Bouchier-Hayes D., Leahy A. (2002) Homocysteine and occlusive arterial disease. Br. J. Surg. 89, 838 844.
42. Pandey S.N., Vaidya A.D., Vaidya R.A., Talwalkar S. (2006) Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality. J. Assoc. Physicians India 54, 769 774.
43. Perna A.F., Castaldo P., De Santo N.G. et al. (2001a) Homocysteine and transmethylations in uremia. Kidney Int. 59, 2299 2308.
44. Perna A.F., Ingrosso D., Satta E. et al. (2001b) Metabolic consequences of hyperhomocysteinemia in uremia. Am. J. Kidney Dis. 38, S85 S90.
45. Perna A.F., Ingrosso D., Lombardi C. et al. (2003) Possible mechanisms of homocysteine toxicity. Kidney Int. 84, S137 S140.
46. Piolot A., Blache D., Boulet L. et al. (2003) Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J. Lab. Clin. Med. 141, 41 49.
47. Pogribny I., Yi P., James S.J. (1999) A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem. Biophys. Res. Commun. 262, 624 628.
48. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C. et al. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43, 985 991.
49. Riccioni G., Bucciarelli T., Mancini B., Di Ilio C., Capra V., D'Orazio N. (2007) The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert. Opin. Investig. Drugs 16, 25 32. (Pubitemid 44964164)
50. Ridker P.M., Stampfer M.J., Rifai N. (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285, 2481 2485.
51. Struys E.A., Jansen E.E., de Meer K., Jakobs C. (2000) Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin. Chem. 46, 1650 1656.
52. Troen A.M., Lutgens E., Smith D.E., Rosenberg I.H., Selhub J. (2003) The atherogenic effect of excess methionine intake. PNAS 100, 15089 15094.
53. Ueland P.M., Refsum H., Beresford S.A., Vollset S.E. (2000) The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr. 72, 324 332.
54. Watanabe M., Osada J., Aratani Y. et al. (1995) Mice deficient in cystathionine ß-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl Acad. Sci. USA 92, 1585 1589.
55. Weiss N., Keller C., Hoffmann U., Loscalzo J. (2002) Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc. Med. 7, 227 239.
56. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., James S.J. (2000) Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275, 29318 29323.
57. Yu X., Chen K., Wei N., Zhang Q., Liu J., Mi M. (2007) Dietary taurine reduces retinal damage produced by photochemical stress via antioxidant and anti-apoptotic mechanisms in Sprague-Dawley rats. Br. J. Nutr. 98, 711 719.
58. Zaina S., Lindholm M.W., Lund G. (2005) Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? J. Nutr. 135, 5 8.
59. Zhang R., Ma J., Xia M., Zhu H., Ling W. (2004) Mild hyperhomocysteinemia induced by feeding rats diets rich in methionine or deficient in folate promotes early atherosclerotic inflammatory processes. J. Nutr. 134, 825 830.
60. Zhou J., Moller J., Danielsen C.C. et al. (2001) Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 1470 1476.